Evidence map›Paper›PMID 41023938›Full record

ReviewBMC nephrology2025

Kansas city cardiomyopathy questionnaire in cardiac function assessment of chronic kidney disease patients: a literature review.

Jiafang Li, Qunli Chen, Yi Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiafang LiDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University (Shenzhen Second People's Hospital), 3002 Sungang Road, Shenzhen, Guangdong, 518035, China.
Qunli ChenDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University (Shenzhen Second People's Hospital), 3002 Sungang Road, Shenzhen, Guangdong, 518035, China.
Yi XuDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University (Shenzhen Second People's Hospital), 3002 Sungang Road, Shenzhen, Guangdong, 518035, China. xuyi20001234@163.com.

Funding

The Sanming Project of Medicine in Shenzhen SZSM202211013The Shenzhen Key Medical Discipline Construction Fund SZXK009
6 · The paper itself

Abstract

Chronic kidney disease (CKD) patients face an increased risk of cardiovascular disease, particularly heart failure (HF). The combination of CKD and HF (CKD-HF) presents significant challenges in diagnosis, assessment, and management due to the unique pathophysiological features of this patient population. The Kansas City Cardiomyopathy Questionnaire (KCCQ), a patient-reported outcomes measure widely used in clinical trials of HF, shows promise in addressing these challenges. However, the effectiveness and application of KCCQ in CKD patients, especially those with heart failure, have not been fully explored. This article aims to review the current evidence of KCCQ in CKD patients, highlighting its potential value while acknowledging the limitations of current research, and suggesting potential clinical applications that warrant further validation.

Indexed as

CardiomyopathiesHeart FailurePatient Reported Outcome MeasuresRenal Insufficiency, ChronicHumansSurveys and QuestionnairesChronic kidney diseaseHeart failureKansas city cardiomyopathy questionnairePatient self-reported outcomes

Identifiers

PMID41023938
PMCPMC12482211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.